|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-6-13
|
|
pubmed:abstractText |
Intensive chemotherapy followed by autologous hematopoietic stem cell transplantation (HSCT) is a curative treatment option for patients with myelodysplastic syndromes (MDS). Peripheral blood (PB) HSCT was introduced in 1992 and PB has become the source of choice of autologous stem cells worldwide. Autologous PB stem cells result in faster hematopoietic recovery, but may be associated with a higher risk of relapse.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1592-8721
|
|
pubmed:author |
pubmed-author:BandiniBeppeB,
pubmed-author:BiersackHaroldH,
pubmed-author:BrandRonaldR,
pubmed-author:DelforgeMichelM,
pubmed-author:GratwohlAloisA,
pubmed-author:KrogerNicolausN,
pubmed-author:MDS subcommittee of the EBMT Chronic Leukemia Working Party,
pubmed-author:MeloniGiovannaG,
pubmed-author:NiederwieserDietgerD,
pubmed-author:OrReuvenR,
pubmed-author:SierraJorgeJ,
pubmed-author:de WitteTheoT,
pubmed-author:van BiezenAnjaA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
91
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
750-6
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16769576-Analysis of Variance,
pubmed-meshheading:16769576-Disease-Free Survival,
pubmed-meshheading:16769576-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:16769576-Hematopoietic Stem Cells,
pubmed-meshheading:16769576-Humans,
pubmed-meshheading:16769576-Leukemia, Myeloid, Acute,
pubmed-meshheading:16769576-Multivariate Analysis,
pubmed-meshheading:16769576-Myelodysplastic Syndromes,
pubmed-meshheading:16769576-Recurrence,
pubmed-meshheading:16769576-Registries,
pubmed-meshheading:16769576-Retrospective Studies,
pubmed-meshheading:16769576-Survival Analysis,
pubmed-meshheading:16769576-Transplantation, Autologous
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes.
|
|
pubmed:affiliation |
Dept. of Hematology, Radboud University Medical Center Nijmegen, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
